MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2
- Type
- Retraction
- Notice date
- 3/1/2021 0:00
- Journal
- European Review for Medical and Pharmacological Sciences
- Publisher
- Verduci Editore
- Notice DOI
- 10.26355/eurrev_202103_25197
- Original paper DOI
- 10.26355/eurrev_201910_19274